Traditional ingredients used in medicines are small, artificially manufactured chemicals which are relatively easy to replicate in big batches. Modern drugs are increasingly made up of much larger, live biological particles which require specialised delivery mechanisms and manufacturing. This is good news for Consort Medical (CSRT). The group has developed a novel range of auto-injectors which can be used for these highly complex medicines. Although launch isn’t expected until 2020, analysts have high hopes for the devices.